Abstract

High risk human papillomavirus (HR-HPV) E2 proteins play roles in transcriptional regulation and are commonly functionally disrupted when the HPV genome integrates into host chromosomes. Some 15-40% of cancer cases, however, contain an intact E2 gene or episomal HPV. In these cases, polymorphism of the E2 gene might be involved. This study aimed to determine polymorphisms of the E2 gene in episomal HPV16 detected in high grade squamous intraepithelial lesions and squamous cell carcinomas and altered functions compared to the E2 prototype. The E2 gene was amplified and sequenced. Two expression vectors containing E2 gene polymorphisms were constructed and transfected in SiHa and C33A cells, then E6 gene as well as Il- 10 and TNF-α expression was determined by quantitative RT-PCR. Expression vectors and reporter vectors containing the HPV16 long control region (LCR) were co-transfected and transcriptional activity was determined. The results showed that a total of 32 nucleotides and 23 amino acids were changed in all 20 cases of study, found in the transactivation (TA) domain, hinge (H) region and DNA binding (DB) domain with 14, 5 and 13 nucleotide positions. They mostly caused amino acid change. The expressing vectors containing different E2 gene polymorphisms showed E6 mRNA suppression, TNF-α mRNA suppression and IL-10 induction but no statistically significant differences when compared to the E2 prototype. Moreover, promoter activity in HPV16 LCR was not affected by E2 protein with different gene polymorphisms, in contrast to nucleotide variations in LCR that showed an effect on transcription activity. These results demonstrated that E2 gene polymorphisms of episomal HPV16 did not affect transcriptional regulation and suggested that nucleotide variation as well as epigenetic modification of the LCR might play a role in inducing malignant transformation of cells containing episomal HPV16.

Highlights

  • Cervical cancer is the third most common cancer among women worldwide

  • The polymorphisms and amino acid changes of the E2 gene in episomal HPV16 detected in high grade squamous intraepithelial lesions (HSIL) and squamous cell carcinoma (SCC) that may be the cause of dysregulation of the HPV oncogenes or the host genes during cervical carcinogenesis were analyzed

  • The data indicated that the HPV16 intact E2 gene contains extensive base changes distributed throughout the entire gene, including the transactivation domain (TAD), hinge region and DNA binding domain (DBD)

Read more

Summary

Introduction

An infection with high risk human papillomavirus (HR-HPV) is necessary for the development of cervical cancer ( Walboomers et al, 1999; Natphopsuk et al, 2013). Wallboomers et al reported that HPV DNA was detected in 99.7% of cervical cancer (Walboomers et al, 1999). HPV16 was the most common type found in cervical carcinoma, accounting alone for about 50% of all cervical cancers (de Sanjose et al, 2010; Shen and Liu, 2013). In the productive HPV infection phase, E6 and E7 oncogene expressions can be controlled by viral E2 protein that can either activate or repress viral oncogene promoter when binding the distal or proximal E2 binding site (E2BS) to promoter (Doeberitz and Vinokurova, 2009). Dysregulation of HR-HPV E6 and E7 oncogene expressions in basal squamous epithelial cells makes the shift from permissive to transforming of HR-HPV-infected cells (Moody and Laimins, 2010)

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.